ATM mutations in patients with hereditary pancreatic cancer.

UNLABELLED Pancreatic cancers are the fourth most-common cause of cancer-related deaths in the Western world, with >200,000 cases reported in 2010. Although up to 10% of these cases occur in familial patterns, the hereditary basis for predisposition in the vast majority of affected families is unknown. We used next-generation sequencing, including whole-genome and whole-exome analyses, and identified heterozygous, constitutional, ataxia telangiectasia mutated (ATM) gene mutations in 2 kindreds with familial pancreatic cancer. Mutations segregated with disease in both kindreds and tumor analysis demonstrated LOH of the wild-type allele. By using sequence analysis of an additional 166 familial pancreatic cancer probands, we identified 4 additional patients with deleterious mutations in the ATM gene, whereas we identified no deleterious mutations in 190 spouse controls (P = 0.046). When we considered only the mostly severely affected families with 3 or more pancreatic cancer cases, 4 deleterious mutations were found in 87 families (P = 0.009). Our results indicate that inherited ATM mutations play an important role in familial pancreatic cancer predisposition. SIGNIFICANCE The genes responsible for the majority of cases of familial pancreatic ductal adenocarcinoma are unknown. We here identify ATM as a predisposition gene for pancreatic ductal adenocarcinoma. Our results have important implications for the management of patients in affected families and illustrate the power of genome-wide sequencing to identify the basis of familial cancer syndromes.

[1]  R. Hruban,et al.  Familial pancreatic cancer. , 2009, Archives of pathology & laboratory medicine.

[2]  B. Lau,et al.  Importance of Age of Onset in Pancreatic Cancer Kindreds , 2010, Journal of the National Cancer Institute.

[3]  Alison P. Klein,et al.  Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene , 2009, Science.

[4]  Sara G. Becker-Catania,et al.  Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. , 1999, American journal of human genetics.

[5]  M. Swift,et al.  Breast and other cancers in families with ataxia-telangiectasia. , 1987, The New England journal of medicine.

[6]  K. Isselbacher,et al.  Heterozygous ATM mutations do not contribute to early onset of breast cancer , 1997, Nature Genetics.

[7]  P. Stenson,et al.  The Human Gene Mutation Database: 2008 update , 2009, Genome Medicine.

[8]  M. Lavin,et al.  Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer , 2008, Nature Reviews Molecular Cell Biology.

[9]  Alan Ashworth,et al.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.

[10]  A. Børresen-Dale,et al.  Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. , 1998, American journal of human genetics.

[11]  A. Ashworth,et al.  Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. , 2009, The New England journal of medicine.

[12]  Y. Shiloh,et al.  Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening. , 1996, American journal of human genetics.

[13]  S. Beghelli,et al.  Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[15]  A. Aurias,et al.  Cancer risk in heterozygotes for ataxia‐telangiectasia , 2001, International journal of cancer.

[16]  Michael A. Choti,et al.  DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors , 2011, Science.

[17]  Y. Shiloh,et al.  Identification of ATM mutations using extended RT‐PCR and restriction endonuclease fingerprinting, and elucidation of the repertoire of A‐T mutations in Israel , 1998, Human mutation.

[18]  P. Byrd,et al.  Molecular pathology of ataxia telangiectasia , 2005, Journal of Clinical Pathology.

[19]  C. Banwell,et al.  The role of ATM in breast cancer development , 2007, Breast Cancer Research and Treatment.

[20]  Michael Krawczak,et al.  The human gene mutation database , 1998, Nucleic Acids Res..

[21]  A. Knudson,et al.  A continuum model for tumour suppression , 2011, Nature.

[22]  M. Swift,et al.  Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. , 1996, Cancer genetics and cytogenetics.

[23]  M. Swift,et al.  Link between breast cancer and ATM gene is strong , 1999, BMJ.

[24]  M. Swift,et al.  Malignant neoplasms in the families of patients with ataxia-telangiectasia. , 1976, Cancer research.

[25]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[26]  R. Hruban,et al.  Large-Scale Allelotype of Pancreaticobiliary Carcinoma Provides Quantitative Estimates of Genome-Wide Allelic Loss , 2004, Cancer Research.

[27]  T. Stankovic,et al.  Mutations associated with variant phenotypes in ataxia-telangiectasia. , 1996, American journal of human genetics.

[28]  D. Seminara,et al.  Pancreatic Cancer Genetic Epidemiology Consortium , 2006, Cancer Epidemiology Biomarkers & Prevention.